WO2024037685A1 - Variants ix de protéase à performance améliorée - Google Patents

Variants ix de protéase à performance améliorée Download PDF

Info

Publication number
WO2024037685A1
WO2024037685A1 PCT/DE2023/100529 DE2023100529W WO2024037685A1 WO 2024037685 A1 WO2024037685 A1 WO 2024037685A1 DE 2023100529 W DE2023100529 W DE 2023100529W WO 2024037685 A1 WO2024037685 A1 WO 2024037685A1
Authority
WO
WIPO (PCT)
Prior art keywords
protease
amino acid
positions
seq
cleaning
Prior art date
Application number
PCT/DE2023/100529
Other languages
German (de)
English (en)
Inventor
Islam SHOHANA
Christian DEGERING
Susanne Wieland
Inken Prueser
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102022208890.5A external-priority patent/DE102022208890A1/de
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2024037685A1 publication Critical patent/WO2024037685A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618—Protease or amylase in liquid compositions only
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin

Definitions

  • the invention lies in the field of enzyme technology.
  • the invention relates to proteases whose amino acid sequence has been changed, particularly with a view to use in detergents and cleaning agents, in particular with regard to liquid detergents and cleaning agents, in order to improve their cleaning performance, and to the nucleic acids encoding them and their production.
  • the invention further relates to the uses of these proteases and processes in which they are used, as well as agents containing them, in particular detergents and cleaning agents, in particular liquid detergents and cleaning agents.
  • proteases are among the most technically important enzymes of all. For detergents and cleaning agents, they are the longest established enzymes and are contained in practically all modern, high-performance detergents and cleaning agents. They break down protein-containing dirt on the items being cleaned. Particularly important here are proteases of the subtilisin type (subtilases, subtilopeptidases, EC 3.4.21.62), which are serine proteases due to the catalytically active amino acids. They act as nonspecific endopeptidases and hydrolyze any acid amide bonds that lie inside peptides or proteins. Their pH optimum is usually in the significantly alkaline range. An overview of this family is provided, for example, in the article "Subtilases: Subtilisin-Iike Proteases" by R.
  • subtilisin enzymes edited by R. Bott and C. Betzel, New York, 1996.
  • Subtilases are produced naturally formed by microorganisms. Of these, the subtilisins formed and secreted by Bacillus species should be mentioned in particular as the most important group within the subtilases.
  • subtilisin-type proteases that are preferably used in detergents and cleaning agents are the subtilisins BPN' and Carlsberg, the protease PB92, the subtilisins 147 and 309, the alkaline protease from Bacillus lentus, in particular from Bacillus lentus DSM 5483, subtilisin DY and the enzymes thermitase, proteinase K and the proteases TW3 and TW7, which can be assigned to the subtilases but no longer to the subtilisins in the narrower sense, as well as variants of the proteases mentioned which have an amino acid sequence that is changed compared to the original protease.
  • Proteases are modified in a targeted or random manner using methods known from the prior art and are thus optimized, for example, for use in detergents and cleaning agents. These include point, deletion or insertion mutagenesis or fusion with other proteins or parts of proteins. Correspondingly optimized variants are known for most of the proteases known from the prior art.
  • EP 2016175 and WO 2021/175697 disclose a protease from Bacillus pumilus or variants thereof intended for detergents and cleaning agents.
  • proteases are suitable for use in liquid surfactant-containing preparations. Many proteases do not show any in such preparations sufficient catalytic performance or they are not sufficiently stable. For the use of proteases in cleaning agents, high catalytic activity and stability under conditions such as those encountered during a washing process are therefore particularly desirable.
  • protease- and surfactant-containing liquid formulations from the prior art have the disadvantage that the proteases contained do not have satisfactory proteolytic activity under standard washing conditions (e.g. in a temperature range of about 20 ° C to about 40 ° C) and / or are not sufficiently stable in storage and the formulations therefore do not show optimal cleaning performance on protease-sensitive soils.
  • protease from Bacillus pumilus or a sufficiently similar protease (based on the sequence identity), which, based on the numbering according to SEQ ID NO: 1 (i), is at positions corresponding to positions 9, 89, 130 , 133, 144, 189, 217, 224, 252 and 271 correspond, the amino acid substitutions P9T, S89A, N130D, T133A, N144K, S189T, Y217M, S224A, N252T and Q271 E and (II) in at least one and increasingly preferred to two , three, four, five or six of the positions corresponding to positions 6, 61, 62, 101, 170 and 188, at least one and increasingly preferably two, three, four, five or six amino acid substitution (s), preferably from the a group consisting of Y6W, F61G, Q62N, D101S, D101 E, D101A, K170G and N188G
  • the invention therefore relates to a protease which has proteolytic activity and comprises an amino acid sequence which corresponds to the amino acid sequence specified in SEQ ID NO:1 over its entire length to at least 70% and increasingly preferably to at least 71%, 72%, 73%, 74 %, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91.5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96, 5%, 97%, 97.5% and 98% is identical, and each based on the numbering according to SEQ ID NO:1, (i) at the positions corresponding to positions 9, 89, 130, 133, 144, 189 , 217, 224, 252 and 271, the amino acid substitutions P9T, S89A, N130D, T133A
  • a preferred subject of the invention is a protease which has proteolytic activity and comprises an amino acid sequence which corresponds to the amino acid sequence specified in SEQ ID NO:1 over its entire length to at least 70% and increasingly preferably to at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91.5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96% , 96.5%, 97%, 97.5% and 98% is identical, and each based on the numbering according to SEQ ID NO:1, (i) at the positions corresponding to positions 9, 89, 130, 133, 144, 189, 217, 224, 252 and 271, the amino acid substitutions P9T, S89A, N130D, T133A, N
  • a further subject of the invention is a method for producing a protease as defined above, comprising introducing (i) the amino acid substitutions P9T, S89A, N130D, T133A, N144K, S189T, Y217M, S224A, N252T and Q271 E at the positions referred to to the numbering according to SEQ ID NO:1 correspond to positions 9, 89, 130, 133, 144, 189, 217, 224, 252 and 271, and (ii) at least one and increasingly preferably two, three, four, five or six Amino acid substitution(s) at at least one and increasingly preferably two, three, four, five or six of the positions corresponding to positions 6, 61, 62, 101, 170 and 188 based on the numbering according to SEQ ID NO:1, preferably selected from the group consisting of Y6W, F61 G, Q62N, D101 S, D101 E, D101A, K170G and N188G, into a starting molecule
  • a protease within the meaning of the present patent application therefore includes both the protease as such and a protease produced using a method according to the invention. All statements on the protease therefore refer both to the protease as such and to the proteases produced using appropriate processes.
  • proteases relate to the nucleic acids encoding these proteases, non-human host cells containing proteases according to the invention or nucleic acids, and agents comprising proteases according to the invention, in particular detergents and cleaning agents, in particular liquid detergents and cleaning agents, washing and cleaning processes, and uses of the proteases according to the invention in detergents or cleaning agents to remove protease-sensitive soiling.
  • agents comprising proteases according to the invention, in particular detergents and cleaning agents, in particular liquid detergents and cleaning agents, washing and cleaning processes, and uses of the proteases according to the invention in detergents or cleaning agents to remove protease-sensitive soiling.
  • At least one means one or more, i.e., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or more .
  • agent and cleaning agent or “washing or cleaning agent” as used herein is synonymous with the term “agent” and refers to a composition for cleaning textiles and / or hard surfaces, in particular dishes, as in the description explained.
  • “Substantially free of” means that the composition or agent contains less than 2% by weight, preferably less than 1% by weight, more preferably less than 0.5% by weight and particularly preferably less than 0. 1% by weight of the corresponding substance, based on the total weight of the composition/agent.
  • Liquid as used herein includes liquids and gels as well as pasty compositions. It is preferred that the liquid compositions be flowable and pourable at room temperature, but it is also possible that they have a yield point.
  • a substance for example a composition or an agent, is solid according to the definition of the invention if it is in the solid state at 25 ° C and 1013 mbar.
  • Liquid also includes gel form.
  • Variant refers to natural or artificially created variations of a native protease that have an amino acid sequence modified from the reference form.
  • the present invention is based on the inventors' surprising finding that amino acid substitutions at the positions described herein result in improved cleaning performance of this modified protease in detergents and cleaning agents.
  • the changes according to the invention result in (i) at the positions which correspond to positions 9, 89, 130, 133, 144, 189, 217, 224, 252 and 271 based on the numbering according to SEQ ID NO:1, and ( ii) at least one of the positions that correspond to positions 6, 61, 62, 101, 170 and 188 based on the numbering according to SEQ ID NO:1, to an improved cleaning performance of this modified protease in detergents and cleaning agents, in particular liquid laundry detergents - and cleaning agents, on at least one and increasingly preferably two, three, four or five protease-sensitive soils, preferably from blood, egg (yellow), milk and other protein-containing soils existing group is/are selected.
  • Proteases according to the invention consequently enable improved removal of at least, preferably several, protease-sensitive stains on textiles and/or hard surfaces, for example dishes.
  • the protease (i) has the amino acid substitutions P9T, S89A, N130D, T133A, N144K, S189T, Y217M, S224A, N252T and Q271 E and (ii) at least one, and increasingly preferably two, three, four, five or six, of the positions corresponding to positions 6, 61, 62, 101, 170 and 188 and increasingly preferably two, three, four, five or six amino acid substitution(s) selected from the group consisting of Y6W, F61G, Q62N, D101S, D101 E, D101A, K170G and N188G, the combination of the amino acid substitutions being Group (i) and the at least one amino acid substitution from group (ii) to an improved cleaning performance of this modified protease in detergents and cleaning agents on at least one and increasingly preferably two, three, four or five protease-sensitive soil(s), which preferably come from the blood, egg (yellow), milk
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which corresponds to the amino acid sequence specified in SEQ ID NO:1 over its entire length to at least 70% and increasingly preferably to at least 71%, 72%, 73 %, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91.5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96% , 96.5%, 97%, 97.5% and 98% is identical, and in each case based on the numbering according to SEQ ID NO:1, has one of the following amino acid substitution combinations: (a) P9T-S89A-D101S-N130D- T133A-N144K-S189T-Y217M-
  • the protease according to the invention comprises one of the following amino acid substitution combinations: (a) P9T-S89A-D101S-N130D-T133A-N144K-S189T-Y217M-S224A-N252T-Q271 E; (b) P9T-S89A-D101E-N130D-T133A-N144K-S189T-Y217M-S224A-N252T-Q271E; (c) P9T-S89A-D101 A-N130D-T133A-N144K-S189T-Y217M-S224A-N252T-Q271 E; (d) Y6W-P9T-S89A-N130D-T133A-N144K-S189T-Y217M-S224A-N252T-Q271E; (e) Y6W-P9T-S89A-N130D-T133A-N144K-S189T-Y2
  • the combinations of the amino acid substitutions according to the invention from groups (i) and (ii) described herein lead to an improved cleaning performance of this modified protease in detergents and cleaning agents, in particular liquid detergents and cleaning agents, on at least one and increasingly preferably on two or three , four, five or six protease-sensitive soil(s), which is/are preferably selected from the group consisting of blood, egg (yellow), milk and other protein-containing soils.
  • Proteases according to the invention consequently enable improved removal of at least one, preferably several, protease-sensitive stains on textiles and/or hard surfaces, such as dishes.
  • Typical protease-sensitive stains include, for example, egg (yellow), blood, milk and other protein-containing stains.
  • An improvement according to the invention in the cleaning performance, in particular the proteolytic cleaning performance, occurs when the protease is applied to at least one and increasingly preferably two, three, four or five protease-sensitive soil(s), which preferably comes from blood, egg (yellow) -, milk and other protein-containing soils is/are selected, shows improved cleaning performance compared to a reference protease, as described herein.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which corresponds to the amino acid sequence specified in SEQ ID NO:1 over its entire length to at least 70% and increasingly preferably to at least 71%, 72%, 73%.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which is at least 70% and increasingly preferably at least 71%, 72%, 73% of the amino acid sequence specified in SEQ ID NO:1 over its entire length.
  • amino acid substitutions preferably selected from the group consisting of Y6W, F61G, Q62N, D101S, D101E, D101A, K170G and N188G, wherein the protease on at least one and increasingly preferably on two , three, four or five protease-sensitive soil(s), which is/are preferably selected from the group consisting of blood, egg (yellow), milk and other protein-containing soils, shows an improved cleaning performance compared to a reference protease, the cleaning performance , as described in Example 2, is determined.
  • the protease according to the invention is a protease which has proteolytic activity and comprises an amino acid sequence which corresponds to the amino acid sequence specified in SEQ ID NO:1 over its entire length to at least 70% and increasingly preferably to at least 71%, 72%, 73 %, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91.5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96% , 96.5%, 97%, 97.5% and 98% is identical, and in each case based on the numbering according to SEQ ID NO:1, has one of the following amino acid substitution combinations: (a) P9T-S89A-D101S-N130D- T133A-N144K-S189T-Y217M-
  • the protease according to the invention comprises one of the following amino acid substitution combinations: (a) P9T-S89A-D101S-N130D-T133A-N144K-S189T-Y217M-S224A-N252T-Q271 E; (b) P9T-S89A-D101E-N130D-T133A-N144K-S189T-Y217M-S224A-N252T-Q271E; (c) P9T-S89A-D101 A-N130D-T133A-N144K-S189T-Y217M-S224A-N252T-Q271 E; (d) Y6W-P9T-S89A-N130D-T133A-N144K-S189T-Y217M-S224A-N252T-Q271E; (e) Y6W-P9T-S89A-N130D-T133A-N144K-S189T-Y2
  • proteases according to the invention have increased catalytic activity in detergents or cleaning agents.
  • the proteases according to the invention can have a proteolytic activity that is at least 101%, 102%, 103%, 104%, 105%, 106%, based on the wild type (SEQ ID NO:1) and/or an already performance-improved starting variant of the protease %, 107%, 108%, 109%, 110%, 111%, 112%, 113%, 114%, 115%, 116%, 117%, 118%, 119%,
  • Such performance-improved proteases enable improved washing results on proteolytic-sensitive soils in different temperature ranges, in particular a temperature range from about 20 ° C to about 40 ° C.
  • preferred embodiments of proteases according to the invention have a particular stability in detergents or cleaning agents, for example to surfactants and/or bleaching agents and/or chelators, and/or to temperature influences, in particular to high temperatures, for example between about 50 ° C and about 65 ° C , in particular about 60 ° C, and / or to acidic or alkaline conditions and / or to pH changes and / or to denaturing or oxidizing agents and / or to proteolytic degradation and / or to a change in redox ratios.
  • Particularly preferred embodiments of the invention therefore provide improved performance and/or more temperature-stable protease variants.
  • performance-improved and more temperature-stable protease variants are provided.
  • Proteases therefore enable improved washing results on protease-sensitive soils in a wide temperature range.
  • cleaning performance is understood to mean the whitening performance on one or more soils, in particular on laundry or dishes.
  • both the washing or cleaning agent which comprises the protease or the washing or cleaning liquor formed by this agent, as well as the protease itself have a respective cleaning performance.
  • the cleaning performance of the enzyme thus contributes to the cleaning performance of the agent or the washing or cleaning liquor formed by the agent.
  • the cleaning performance is preferably determined as stated below.
  • Washing liquor is understood to mean the working solution containing the detergent or cleaning agent which acts on textiles or fabrics or hard surfaces and thus comes into contact with the dirt present on textiles or fabrics or hard surfaces.
  • the washing liquor is usually created when the washing or cleaning process begins and the detergent or cleaning agent is diluted with water, for example in a dishwasher, a washing machine or in another suitable container.
  • proteases according to the invention have enzymatic activity, i.e. they are capable of hydrolyzing peptides and proteins, especially in a detergent or cleaning agent.
  • a protease according to the invention is therefore an enzyme which catalyzes the hydrolysis of amide/peptide bonds in protein/peptide substrates and is thereby able to cleave proteins or peptides.
  • a protease according to the invention is preferably a mature protease, i.e. the catalytically active molecule without signal and/or propeptide(s). Unless otherwise stated, the sequences given also refer to mature (processed) enzymes.
  • the protease is a free enzyme. This means that the protease can act directly with all components of an agent and, if the agent is a liquid agent, that the protease is in direct contact with the agent's solvent (e.g. water).
  • an agent may contain proteases that form an interaction complex with other molecules or that contain a "coating.”
  • a single or several protease molecules can be separated from the other components of the agent by a structure surrounding them.
  • a separating structure can arise from, but is not limited to, vesicles such as a micelle or a liposome.
  • the surrounding structure can also be a virus particle, a bacterial cell or a eukaryotic cell.
  • an agent may contain cells of Bacillus pumilus or Bacillus subtilis expressing the proteases of the invention or cell culture supernatants of such cells.
  • a protease has the specified substitutions means that it contains one (of the specified) substitution(s) at the respective position, ie at least the specified positions do not mutate in any other way or, for example, by fragmentation of the protease.
  • the proteases described herein have the sequence of SEQ ID NO:1 with the exception of the explicitly mentioned substitutions, that is, apart from the substituted positions, they are 100% identical to the sequence according to SEQ ID NO:1.
  • sequence comparison The identity of nucleic acid or amino acid sequences is determined by sequence comparison. This sequence comparison is based on the BLAST algorithm established and commonly used in the prior art (cf. e.g. Altschul et al. (1990) Basic local alignment search tool, J. Mol. Biol., 215:403-410, and Altschul et al (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res., 25:3389-3402) and is basically done by similar sequences of nucleotides or amino acids in the nucleic acid or amino acid sequences be assigned. A tabular assignment of the relevant positions is called alignment. Another algorithm available in the art is the FASTA algorithm.
  • Sequence comparisons are created using computer programs.
  • the Clustal series see e.g. Chenna et al. (2003) Multiple sequence alignment with the Clustal series of programs, Nucleic Acid Res., 31:3497-3500
  • T-Coffee see e.g. Notredame et al. (2000) T-Coffee: A novel method for multiple sequence alignments, J. Mol. Biol., 302:205-217 or programs that are based on these programs or algorithms.
  • Sequence comparisons are also possible using the computer program Vector NTI® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the specified standard parameters, whose AlignX module for sequence comparisons is based on ClustalW, or Clone Manager 10 (Use of the BLOSUM 62 scoring matrix for sequence alignment at the amino acid level). Unless otherwise stated, sequence identity reported herein is determined using the BLAST algorithm.
  • Such a comparison also allows a statement to be made about the similarity of the compared sequences to one another. It is usually given in percent identity, i.e. the proportion of identical nucleotides or amino acid residues in the same positions or in positions corresponding to one another in an alignment.
  • percent identity i.e. the proportion of identical nucleotides or amino acid residues in the same positions or in positions corresponding to one another in an alignment.
  • homology includes conserved amino acid exchanges in amino acid sequences, i.e. amino acids with similar chemical activity, since these usually exert similar chemical activities within the protein. Therefore, the similarity of the compared sequences can also be indicated as percent homology or percent similarity. Identity and/or homology statements can be made about entire polypeptides or genes or just about individual regions. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by similarities in the sequences.
  • identity or homology information in the present application refers to the total length of the nucleic acid or amino acid sequence specified in each case.
  • identity or homology information in the present application refers to the total length of the nucleic acid or amino acid sequence specified in each case.
  • the statement that an amino acid position corresponds to a numerically designated position in SEQ ID NO:1 therefore means that the corresponding position is assigned to the numerically designated position in SEQ ID NO:1 in an alignment as defined above. Furthermore, the assignment of the positions depends on the mature protein.
  • the amino acid sequence of a protease according to the invention comprises a higher number of amino acid residues than the protease according to SEQ ID NO:1.
  • the change positions in a protease according to the invention are those that are assigned to these positions in an alignment.
  • proteases according to the invention can have further amino acid changes, in particular amino acid substitutions, insertions or deletions.
  • Such proteases are, for example, further developed through targeted genetic modification, i.e. through mutagenesis processes, and optimized for specific purposes or with regard to specific properties (for example with regard to their catalytic activity, stability, etc.).
  • nucleic acids according to the invention can be introduced into recombination approaches and thus used to generate completely new proteases or other polypeptides. The aim is to introduce targeted mutations such as substitutions, insertions or deletions into the known molecules in order, for example, to improve the cleaning performance of enzymes according to the invention.
  • the surface charges and/or the isoelectric point of the molecules and thereby their interactions with the substrate can be changed.
  • the net charge of the enzymes can be changed in order to influence substrate binding, especially for use in detergents and cleaning agents.
  • one or more corresponding mutations can increase the stability or catalytic activity of the protease and thereby improve its cleaning performance.
  • Advantageous properties of individual mutations, e.g. individual substitutions, can complement each other. Proteases that have already been optimized with regard to certain properties, for example with regard to their stability during storage, can therefore be further developed further within the scope of the invention.
  • amino acid exchanges For the description of substitutions that affect exactly one amino acid position (amino acid exchanges), the following convention is used here: first the naturally present amino acid is designated in the form of the internationally used single-letter code, then follows the associated sequence position and finally the inserted amino acid. Multiple or alternative substitutions within the same polypeptide chain are separated by slashes. "130D/V” means that position 130 has mutated to D or V. In insertions, additional amino acids are named after the sequence position. In the case of deletions, the missing amino acid is replaced by a symbol, for example a star or a dash, or an A is indicated before the corresponding position.
  • P9T describes the substitution of proline at position 9 by threonine
  • P9TH describes the insertion of histidine after the amino acid threonine at position 9
  • P9* or AP9 describes the deletion of proline at position 9.
  • a further subject of the invention is therefore a protease which is characterized in that it is obtainable from a protease as described herein as a starting molecule by single or multiple conservative amino acid substitution, the protease in the count according to SEQ ID NO:1 being at least one of the Has amino acid substitutions described above.
  • conservative amino acid substitution means the exchange (substitution) of an amino acid residue for another amino acid residue, whereby this exchange does not lead to a change in polarity or charge at the position of the exchanged amino acid, e.g. the exchange of a non-polar amino acid residue for another non-polar amino acid residue.
  • the protease is characterized in that it is obtainable from a protease according to the invention as a starting molecule by fragmentation, deletion, insertion or substitution mutagenesis and comprises an amino acid sequence which has a length of at least 190, 200, 210, 220, 230, 240, 250, 260, 270, 271, 272, 273, 274 or 275 contiguous amino acids match the starting molecule, the protease, in each case based on the numbering according to SEQ ID NO:1, (i) at the positions corresponding to the positions 9, 89, 130, 133, 144, 189, 217, 224, 252 and 271, which correspond to amino acid substitutions P9T, S89A, N130D, T133A, N144K, S189T, Y217M, S224A, N252T and Q271 E, and (ii) at least one and increasingly preferably two, three, four, five or six of the positions corresponding to positions 6, 61,
  • the enzymes retain their proteolytic activity even after mutagenesis, i.e. their proteolytic activity corresponds at least to that of the starting enzyme, i.e. in a preferred embodiment the proteolytic activity is at least 100%, preferably at least 120%, of the activity of the starting enzyme.
  • Other substitutions can also have beneficial effects. Both single and several contiguous amino acids can be exchanged for other amino acids.
  • Advantageous positions for sequence changes, in particular substitutions, of the protease according to SEQ ID NO:1, which are preferably important when transferred to homologous positions of the proteases according to the invention and give the protease advantageous functional properties, are therefore the positions that are in an alignment with the positions described herein correspond, ie in the count according to SEQ ID NO:1.
  • the positions mentioned are in the wild-type molecule the protease has the following amino acid residues: 6Y, 9P, 61 F, 62Q, 89A, 101 D, 130N 133T, 144K, 170K, 188N, 189S, 217Y, 224S, 252N, 271 Q.
  • an amino acid exchange in a specific position of the protease from Bacillus pumilus according to SEQ ID NO:1 is accompanied by a change in an enzymatic parameter, for example with an increase in the KM value, and a corresponding change in the enzymatic parameter, for example also an increase of the KM value, observed in a protease variant according to the invention, the amino acid exchange of which was achieved by the same introduced amino acid, this can be seen as a confirmation of the correct assignment.
  • a method according to the invention further comprises one or more of the following method steps:
  • the protease comprises an amino acid sequence which is at least 190, 200, 210, 220, 230, 240, 250, 260, 270, 271 in length , 272, 273, 274 or 275 contiguous amino acids match the starting molecule, the protease, in each case based on the numbering according to SEQ ID NO:1, (i) at positions corresponding to positions 9, 89, 130, 133, 144 , 189, 217, 224, 252 and 271, the amino acid substitutions P9T, S89A, N130D, T133A, N144K, S189T, Y217M, S224A, N252T and Q271 E, and (ii) at least one and increasingly preferably two, three, four , five or six of the positions corresponding to positions 6, 61, 62, 101, 170 and 188, at least one and increasingly preferably two, three, four, five
  • a previously described protease is stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer.
  • Increasing the stability during storage and/or use, for example during the washing process results in the enzymatic activity lasting longer and thus the cleaning performance being improved.
  • all stabilization options described and/or appropriate in the prior art can be considered. Those stabilizations that are achieved via mutations of the enzyme itself are preferred, since such stabilizations do not require any further work steps after the enzyme has been obtained. Examples of sequence changes suitable for this are mentioned above. Other suitable sequence changes are known from the prior art.
  • Changing the binding of metal ions, in particular the calcium binding sites for example by replacing one or more of the amino acids involved in the calcium binding with one or more negatively charged amino acids and / or by introducing sequence changes in at least one of the sequences both amino acids arginine/glycine;
  • Preferred embodiments are those in which the enzyme is stabilized in several ways, since several stabilizing mutations act additively or synergistically.
  • the protease according to the invention can be combined with at least one reversible inhibitor compound, which consists of polyols, in particular glycerol and 1,2-propylene glycol, benzamidine hydrochloride, borax, boric acids, boronic acids or their salts or esters or derivatives, in particular phenylboronic acid derivatives or 4-formylphenylboronic acid ( 4-FPBA), compounds of formulas (I) or (II) where R is each selected from -COOH, Ci-e-alkyl-substituted or unsubstituted C2-6-dicarboxylic acids, Ci-e-alkyl-substituted or unsubstituted C2-e-carboxylic acids and -OOC-NR 2 2, where R 2 is the same or different and selected from Ci-e-alkyl or H, as well as salts, esters or derivatives thereof, preferably benzoic acid, phenylmalonic acid, benzy
  • phenylboronic acid derivative is understood to mean a compound with the formula (III).
  • the compound of formula (III) has the following structural formula: where R is hydrogen, a hydroxyl, a C1-6 alkyl, a substituted C1-6 alkyl, a C1-6 alkenyl or a substituted C1-6 alkenyl group.
  • the radical R in the phenylboronic acid derivative is preferably a C1-6 alkyl group and, among these, is more preferably -CH3, -CH3CH2 or -CH3CH2CH2. More preferably, the radical R in the phenylboronic acid derivative is hydrogen.
  • the phenylboronic acid derivative 4-formylphenylboronic acid (4-FPBA) is particularly preferred.
  • the reversible inhibitor compound used can be boric acid.
  • the reversible inhibitor compound used can be a compound of the formulas (I) or (II) where R is each selected from -COOH, Ci-e-alkyl-substituted or unsubstituted C2-6-dicarboxylic acids, Ci-e-alkyl-substituted or unsubstituted C2-e-carboxylic acids and -OOC-NR 2 2, where R 2 is the same or different and selected from Ci-e-alkyl or H, as well as salts, esters or derivatives thereof, and combinations thereof, and preferably selected from the group consisting of benzoic acid, phenylmalonic acid, benzylmalonic acid, phenylsuccinic acid, benzylsuccinic acid, methyl-3 -Benzoyl propionate, (S)-3-phenylbutyric acid and benzyl carbamate group.
  • the protease according to the invention is used in agents or compositions that are essentially free of boron-containing compounds.
  • “Substantially free of boron-containing compounds” in this context means that the corresponding agents or compositions contain less than 2% by weight, preferably less than 1% by weight, more preferably less than 0.5% by weight and particularly preferred contain less than 0.1% by weight of boron-containing compounds, based on the total weight of the agent/composition.
  • these agents/compositions are free of boron-containing compounds, i.e. in particular they do not contain any boric acid and/or phenylboronic acid derivatives.
  • the protease is characterized in that its cleaning performance is not significantly reduced compared to the wild-type enzyme (SEQ ID NO:1) or a starting variant (reference protease), that is to say it has at least 80% of the reference washing performance, preferably at least 100% more preferably at least 110%, particularly preferably at least 120% or more.
  • the cleaning performance can be determined in a washing system that contains a detergent in a dosage of between 2.0 and 8.0 grams per liter of washing liquor and the enzyme.
  • the enzymes to be compared are used in the same concentration (based on active protein).
  • the use of the respective enzymes with the same activity ensures that even if there is a discrepancy in the ratio of active substance to total protein (the values of the specific activity), the respective enzymatic properties, i.e. the cleaning performance on certain types of soiling, are compared. In general, low specific activity can be compensated for by adding a larger amount of protein.
  • the enzymes to be examined can also be used in the same amount or weight if the enzymes to be examined have a different affinity for the test substrate in an activity test.
  • the expression “same amount of substance” in this context refers to the same molar use of the enzymes to be examined.
  • the expression “equal weight” refers to an equal weight use of the enzymes to be examined.
  • the concentration of the protease in the detergent intended for such a washing system is 0.001 to 0.1% by weight, preferably 0.01 to 0.06% by weight, based on active protein.
  • Washing or cleaning performance is understood to mean the ability of a detergent or cleaning agent to partially or completely remove an existing soil, in particular the whitening performance of one or more soils on textiles, in particular cotton textiles, polyester textiles and/or cotton-polyester blended textiles.
  • soiling are blood on cotton or chocolate-milk/soot on cotton, cocoa on cotton, egg yolk on cotton, milk/soot on cotton or porridge on cotton, etc.
  • Other examples include the aforementioned soiling on cotton-polyester blended textiles or polyester-containing textiles or other mixed textiles.
  • both the washing or cleaning agent which comprises the protease, or the washing or cleaning liquor formed by this agent, as well as the protease itself have a respective cleaning performance. The cleaning performance of the protease thus contributes to the cleaning performance of the agent or the washing or cleaning liquor formed by the agent.
  • Washing or cleaning liquor is understood to mean the working solution containing the detergent or cleaning agent which acts on the textiles or hard surfaces and thus comes into contact with the dirt present on the textiles or hard surfaces.
  • the washing or cleaning liquor is usually created when the washing or cleaning process begins and the washing or cleaning agent is diluted with water, for example in a washing machine or dishwasher or in another suitable container.
  • a liquid reference detergent for such a washing system can, for example, be composed as follows (all information in percent by weight (wt.%)): 4.4% alkylbenzenesulfonic acid, 5.6% other anionic surfactants, 2.4% C12-18 Na -Salts of fatty acids (soaps), 4.4% non-ionic surfactants, 0.2% phosphonates, 1.4% citric acid, 0.95% NaOH, 0.01% defoamer, 2% glycerin, 0.08% preservatives , 1% ethanol, remainder demineralized water.
  • the dosage of the liquid detergent is preferably between 4.5 and 6.0 grams per liter of washing liquor, for example 4.7, 4.9 or 5.9 grams per liter of washing liquor. Washing is preferred in a pH range between pH 7 and pH 10.5, preferably between pH 8 and pH 9.
  • the cleaning performance against soiling on cotton is determined by measuring the degree of cleaning of the washed textiles.
  • the washing process can take place for 60 minutes at a temperature of around 20°C or around 40°C and the water can have a hardness of between 15.5°dH and 16.5°dH (German hardness).
  • the cleaning performance is determined, for example, at 20 ° C or 40 ° C using a liquid detergent such as that specified above, the washing process preferably taking place for 60 minutes at 600 rpm.
  • the degree of whiteness i.e. the lightening of the dirt
  • the degree of whiteness is determined using optical measuring methods, preferably photometrically.
  • a suitable device for this is, for example, the Minolta CM508d spectrometer.
  • the devices used for the measurement are usually calibrated beforehand with a white standard, preferably a supplied white standard.
  • Preferred embodiments of proteases according to the invention achieve such advantageous cleaning performance even at low temperatures, in particular in the temperature ranges between about 10 ° C and about 60 ° C, preferably between about 15 ° C and about 50 ° C and particularly preferably between about 20 ° C and about 40°C.
  • protease activity can be determined via the release of the chromophore para-nitroaniline (pNA) from the substrate suc-L-Ala-L-Ala-L-Pro-L-Phe-p-nitroanilide (AAPF).
  • pNA chromophore para-nitroaniline
  • the protease cleaves the substrate and releases pNA.
  • the release of pNA causes an increase in the absorbance at 410 nm, the time course of which is a measure of the enzymatic activity (cf. Del Mar et al., 1979).
  • the measurement is carried out at a temperature of 25°C, at pH 8.6, and a wavelength of 410 nm.
  • the measurement time is 5 min and the measurement interval is 20 s to 60 s.
  • the protease activity is usually expressed in protease units (PE ) specified. Suitable protease activities are, for example, 2.25, 5 or 10 PE per ml of wash liquor. However, the protease activity is not zero.
  • An alternative test for determining the proteolytic activity of the proteases according to the invention is an optical measurement method, preferably a photometric method.
  • the test suitable for this involves the protease-dependent cleavage of the substrate protein casein. This is broken down by the protease into a large number of smaller partial products. The entirety of these partial products has an increased absorption at 290 nm compared to non-cleaved casein, whereby this increased absorption can be determined using a photometer and thus a conclusion can be drawn about the enzymatic activity of the protease.
  • the protein concentration can be determined using known methods, for example the BCA method (bicinchoninic acid; 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the Biuret method (Gornall et al., J. Biol. Chem. 177 (1948): 751-766).
  • the active protein concentration can be determined by titrating the active centers using a suitable irreversible inhibitor and determining the residual activity (cf. Bender et al., J. Am. Chem. Soc. 88, 24 (1966): 5890-5913).
  • a further subject of the invention is a protease as described above, which is characterized in that it has at least one chemical modification.
  • a protease with such a change is called a derivative, meaning the protease is derivatized.
  • derivatives are understood to mean proteins whose pure amino acid chain has been chemically modified.
  • derivatizations can occur, for example, in vivo by the host cell that expresses the protein.
  • couplings of low molecular weight compounds such as lipids or oligosaccharides are particularly noteworthy.
  • derivatizations can also be carried out in vitro, for example by chemically converting a side chain of an amino acid or by covalently binding another compound to the protein.
  • Such another compound can also be another protein, which is bound to a protein according to the invention, for example via bifunctional chemical compounds.
  • Derivatization also means covalent binding to a macromolecular carrier, or non-covalent inclusion in suitable macromolecular cage structures. Derivatizations can, for example, influence the substrate specificity or the binding strength to the substrate or cause a temporary blocking of the enzymatic activity if the coupled substance is an inhibitor. This can be useful, for example, for the storage period. Such modifications may further affect stability or enzymatic activity. They can also serve to reduce the allergenicity and/or immunogenicity of the protein and thus, for example, to increase its skin compatibility.
  • couplings with macromolecular compounds can improve the protein in terms of stability and/or skin compatibility.
  • Derivatives of a protein according to the invention can also be understood in the broadest sense as preparations of these proteins.
  • a protein can be combined with various other substances, for example from the culture of the producing microorganisms.
  • a protein can also have been specifically mixed with other substances, for example to increase its storage stability. All preparations of a protein according to the invention are therefore also in accordance with the invention. This is also independent of whether it actually develops this enzymatic activity in a particular preparation or not.
  • proteases or protease variants and/or derivatives described above those whose storage stability and/or their cleaning performance are particularly preferred in the context of the present invention the initial variant is improved, with the cleaning performance in a washing system being determined as described herein.
  • a further subject of the invention is a nucleic acid which codes for a protease according to the invention, and a vector containing such a nucleic acid, in particular a cloning vector or an expression vector.
  • a nucleic acid which codes for a protease according to the invention
  • a vector containing such a nucleic acid in particular a cloning vector or an expression vector.
  • These can be DNA or RNA molecules. They can be present as a single strand, as a single strand complementary to this single strand, or as a double strand.
  • the sequences of both complementary strands must be taken into account in all three possible reading frames.
  • different codons i.e. base triplets, can code for the same amino acids, so that a specific amino acid sequence can be coded by several different nucleic acids.
  • nucleic acid sequences that can encode one of the proteases described above are included in this subject matter of the invention.
  • the person skilled in the art is able to determine these nucleic acid sequences without any doubt because, despite the degeneracy of the genetic code, defined amino acids can be assigned to individual codons. Therefore, starting from an amino acid sequence, the person skilled in the art can easily determine nucleic acids that code for this amino acid sequence.
  • one or more codons can be replaced by synonymous codons. This aspect relates in particular to the heterologous expression of the enzymes according to the invention.
  • Each organism for example a host cell of a production strain, has a specific codon usage.
  • Codon use means the translation of the genetic code into amino acids by the respective organism. Bottlenecks in protein biosynthesis can occur if the codons on the nucleic acid are confronted with a comparatively small number of loaded tRNA molecules in the organism. Although encoding the same amino acid, this results in a codon being translated less efficiently in the organism than a synonymous codon encoding the same amino acid. Due to the presence of a higher number of tRNA molecules for the synonymous codon, it can be translated more efficiently in the organism.
  • vectors are understood to mean elements consisting of nucleic acids which contain a nucleic acid according to the invention as a characteristic nucleic acid region. They are able to establish this as a stable genetic element in a species or a cell line over several generations or cell divisions.
  • Vectors are special plasmids, i.e. circular genetic elements, especially when used in bacteria.
  • a nucleic acid according to the invention is converted into one Vector cloned.
  • the vectors include, for example, those whose origins are bacterial plasmids, viruses or bacteriophages, or predominantly synthetic vectors or plasmids with elements from a wide variety of origins.
  • vectors are able to establish themselves as stable units in the relevant host cells over several generations. They can exist extrachromosomally as separate units or integrate into a chromosome or chromosomal DNA.
  • Expression vectors include nucleic acid sequences which enable them to replicate in the host cells containing them, preferably microorganisms, particularly preferably bacteria, and to express a nucleic acid contained there. Expression is particularly influenced by the promoter(s) that regulate transcription. In principle, expression can take place through the natural promoter originally located in front of the nucleic acid to be expressed, but also through a host cell promoter provided on the expression vector or through a modified or a completely different promoter from another organism or another host cell.
  • At least one promoter for the expression of a nucleic acid according to the invention is made available and used for its expression.
  • Expression vectors can also be regulated, for example by changing the cultivation conditions or when the host cells they contain reach a certain cell density or by adding certain substances, in particular activators of gene expression.
  • An example of such a substance is the galactose derivative isopropyl-ß-D-thiogalactopyranoside (IPTG), which is used as an activator of the bacterial lactose operon (lac operon).
  • IPTG galactose derivative isopropyl-ß-D-thiogalactopyranoside
  • lac operon lac operon
  • a further subject of the invention is a non-human host cell which contains a nucleic acid according to the invention or a vector according to the invention, or which contains a protease according to the invention, in particular one which secretes the protease into the medium surrounding the host cell.
  • a nucleic acid according to the invention or a vector according to the invention is preferably transformed into a microorganism, which then represents a host cell according to the invention.
  • individual components, ie nucleic acid parts or fragments of a nucleic acid according to the invention can also be introduced into a host cell in such a way that the resulting host cell then contains a nucleic acid according to the invention or a vector according to the invention.
  • This procedure is particularly suitable if the host cell already contains one or more components of a nucleic acid according to the invention or a vector according to the invention and the other components are then supplemented accordingly.
  • Methods for transforming cells are established in the prior art and are well known to those skilled in the art. In principle, all cells are suitable as host cells, i.e. prokaryotic or eukaryotic cells. Preferred are those host cells that can be handled in a genetically advantageous manner, for example in terms of transformation with the nucleic acid or vector and its stable establishment, for example single-celled fungi or bacteria. Furthermore, preferred host cells are characterized by good microbiological and biotechnological manageability.
  • Preferred host cells according to the invention secrete the (transgenically) expressed protein into the medium surrounding the host cells.
  • the proteases can be modified by the cells that produce them after their production, for example by attaching sugar molecules, formylation, amination, etc. Such post-translational modifications can functionally influence the protease.
  • Further preferred embodiments represent host cells whose activity can be regulated due to genetic regulatory elements that are provided, for example, on the vector, but can also be present in these cells from the outset. For example, by controlled addition of chemical compounds that serve as activators, by changing the cultivation conditions or when a certain cell density is reached, these can be stimulated to express themselves. This enables economical production of the proteins according to the invention.
  • An example of such a connection is IPTG as described above.
  • Preferred host cells are prokaryotic or bacterial cells.
  • Bacteria are characterized by short generation times and low demands on cultivation conditions. This allows cost-effective cultivation processes or manufacturing processes to be established. The expert also has a wealth of experience with bacteria in fermentation technology.
  • Gram-negative or gram-positive bacteria may be suitable for a specific production for a variety of reasons that can be determined experimentally in individual cases, such as nutrient sources, product formation rate, time required, etc.
  • gram-negative bacteria such as Escherichia coli, a large number of proteins are secreted into the periplasmic space, i.e. into the compartment between the two membranes enclosing the cells. This can be advantageous for special applications.
  • gram-negative bacteria can also be designed in such a way that they release the expressed proteins not only into the periplasmic space, but into the medium surrounding the bacterium.
  • Gram-positive bacteria such as Bacilli or Actinomycetes or other representatives of the Actinomycetales do not have an outer membrane, so that secreted proteins are immediately released into the medium surrounding the bacteria, usually the nutrient medium, from which the expressed proteins can be purified. They can be isolated directly from the medium or further processed.
  • gram-positive bacteria are related or identical to most organisms of origin for technically important enzymes and usually produce comparable enzymes themselves, so that they have similar codon usage and their protein synthesis apparatus is naturally aligned accordingly.
  • Host cells according to the invention can be modified in terms of their requirements for the culture conditions, have other or additional selection markers or express other or additional proteins. In particular, these can also be host cells that transgenically express several proteins or enzymes.
  • the present invention is in principle applicable to all microorganisms, in particular to all fermentable microorganisms, particularly preferably to those of the genus Bacillus, and means that proteins according to the invention can be produced by using such microorganisms. Such microorganisms then represent host cells within the meaning of the invention.
  • the host cell is characterized in that it is a bacterium, preferably one selected from the group of genera Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacte um, Arthrobacter, Streptomyces, Stenotrophomonas and Pseudomonas, more preferably one, which is selected from the group of Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus lentus, Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus alcalophilus, Bacillus globigii, Bacillus gibsonii, Bacillus clausii, Bacillus halodurans, Bacillus pumilus, Staphylococcus camosus, Corynebacterium glutamicum, Arthrobacter oxidans, Streptomyces lividans, Streptomyces co
  • the host cell can also be a eukaryotic cell, which is characterized by the fact that it has a nucleus.
  • a further subject of the invention is therefore a host cell which is characterized in that it has a cell nucleus.
  • eukaryotic cells are capable of post-translationally modifying the protein formed. Examples of this are fungi such as actinomycetes or yeasts such as Saccharomyces or Kluyveromyces. This can be particularly advantageous, for example, if the proteins are to undergo specific modifications in connection with their synthesis that make such systems possible.
  • modifications that eukaryotic systems carry out, particularly in connection with protein synthesis include, for example, the binding of low-molecular compounds such as membrane anchors or oligosaccharides. Such oligosaccharide modifications may be desirable, for example, to reduce the allergenicity of an expressed protein. Co-expression with the enzymes naturally formed by such cells, such as cellulases, can also be advantageous. Furthermore, for example, thermophilic fungal expression systems can be particularly suitable for expressing temperature-stable proteins or variants.
  • the host cells according to the invention are cultivated and fermented in the usual way, for example in discontinuous or continuous systems.
  • a suitable nutrient medium is inoculated with the host cells and the product is harvested from the medium after a period of time to be determined experimentally.
  • Continuous fermentations are characterized by reaching a steady state in which cells partially die over a comparatively long period of time but also grow back and at the same time the protein formed can be removed from the medium.
  • Host cells according to the invention are preferably used to produce proteases according to the invention.
  • a further subject of the invention is therefore a method for producing a protease comprising a) cultivating a host cell according to the invention, and b) isolating the protease from the culture medium or from the host cell.
  • This subject matter of the invention preferably includes fermentation processes. Fermentation processes are known from the prior art and represent the actual large-scale production step, usually followed by a suitable purification method of the product produced, for example that according to the invention Proteases. All fermentation processes that are based on a corresponding process for producing a protease according to the invention represent embodiments of this subject matter of the invention. Fermentation processes that are characterized in that the fermentation is carried out via a feed strategy are particularly suitable. The media components that are consumed by ongoing cultivation are added. As a result, considerable increases can be achieved both in cell density and in cell mass or dry mass and/or in particular in the activity of the protease of interest.
  • the fermentation can also be designed in such a way that undesirable metabolic products are filtered out or neutralized by adding buffer or appropriate counterions.
  • the produced protease can be harvested from the fermentation medium. Such a fermentation process is preferred over isolation of the protease from the host cell, ie product preparation from the cell mass (dry mass), but requires the provision of suitable host cells or one or more suitable secretion markers or mechanisms and / or transport systems so that the host cells Secrete protease into the fermentation medium.
  • the protease can be isolated from the host cell, ie purified from the cell mass, for example by precipitation with ammonium sulfate or ethanol, or by chromatographic purification.
  • a further subject of the invention is an agent which is characterized in that it contains a protease according to the invention as described above.
  • the agent is preferably a detergent or cleaning agent.
  • the detergent and cleaning agent is essentially free of boron-containing compounds. “Substantially free of boron-containing compounds” in this context means that the agents according to the invention contain less than 2% by weight, preferably less than 1% by weight, more preferably less than 0.5% by weight and particularly preferably less than 0.1% by weight of boron-containing compounds, based on the total weight of the agent.
  • the detergents and cleaning agents according to the invention are free of boron-containing compounds, i.e. in particular they do not contain any boric acid and/or phenylboronic acid derivatives.
  • a detergent or cleaning agent is understood to mean all conceivable types of detergent or cleaning agent, both concentrates and undiluted agents, for use on a commercial scale, in the washing machine or for hand washing or cleaning.
  • detergents for textiles, carpets, or natural fibers, for which the term detergent is used.
  • dishwashing detergents for dishwashers (automatic dishwashing detergents) or manual dishwashing detergents or cleaners for hard surfaces such as metal, glass, porcelain, ceramics, tiles, stone, painted surfaces, plastics, wood or leather, for which the term cleaning agent is used
  • manual dishwashing detergents for example also scouring agents, glass cleaners, toilet fresheners, etc.
  • the invention also includes washing aids that are added to the actual detergent when washing textiles manually or by machine in order to achieve a further effect.
  • detergents and cleaning agents within the scope of the invention also include textile pre- and post-treatment agents, i.e. those agents with which the item of laundry is brought into contact before the actual laundry, for example to dissolve stubborn dirt, and also those agents that are in one of the actual The step after textile washing gives the laundry other desirable properties such as a pleasant feel, crease resistance or low static charge.
  • the last-mentioned agents include fabric softeners.
  • the detergents or cleaning agents according to the invention which can be present as powdery or granular solids, in compressed or post-compacted particle form, as homogeneous solutions or suspensions, can contain, in addition to a protease according to the invention, all known ingredients that are customary in such agents, with preferably at least one further ingredient in the means is available.
  • the agents according to the invention can in particular contain surfactants, builders (builders), polymers, glass corrosion inhibitors, corrosion inhibitors, bleaching agents such as peroxygen compounds, bleach activators or bleach catalysts.
  • They can also contain water-miscible organic solvents, other enzymes, enzyme stabilizers, sequestering agents, electrolytes, pH regulators and/or other auxiliary substances such as optical brighteners, graying inhibitors, color transfer inhibitors, foam regulators as well as dyes and fragrances and combinations thereof.
  • An agent according to the invention advantageously contains the protease according to the invention in an amount of 2 pg to 20 mg, preferably from 5 pg to 17.5 mg, particularly preferably from 20 pg to 15 mg and most preferably from 50 pg to 10 mg per g of the agent .
  • the concentration of the protease (active enzyme) described herein in the agent is >0 to 1% by weight, preferably 0.0001 or 0.001 to 0.1% by weight based on the total weight of the agent or composition.
  • An agent according to the invention increasingly preferably contains the protease in an amount of 1 x 10 -8 to 5% by weight, from 0.0001 to 1% by weight, from 0.0005 to 0.5% by weight, from 0.001 up to 0.1% by weight, based on active protein and based on the total weight of the detergent.
  • the embodiments of the present invention include all solid, powdery, liquid, gel or pasty dosage forms of agents according to the invention, which may also consist of several phases and may be in compressed or non-compressed form.
  • the agent can be in the form of a free-flowing powder, in particular with a bulk density of 300 g/l to 1200 g/l, in particular 500 g/l to 900 g/l or 600 g/l to 850 g/l.
  • the solid dosage forms of the agent also include extrudates, granules, tablets or Pouches.
  • the agent can also be liquid, gel or pasty, for example in the form of a non-aqueous liquid detergent or a non-aqueous paste or in the form of an aqueous liquid detergent or a water-containing paste.
  • Liquid assets are generally preferred.
  • the agent can be present as a one-component system. Such means consist of one phase. Alternatively, a means can also consist of several phases. Such a product is therefore divided into several components.
  • the proteases according to the invention are preferably used in liquid detergents for cleaning textiles, particularly preferably in liquid detergents with a pH of about 8 to about 9.
  • Detergents or cleaning agents according to the invention can only contain a protease according to the invention. Alternatively, they can also contain further hydrolytic enzymes or other enzymes in a concentration appropriate for the effectiveness of the agent. A further embodiment of the invention therefore represents agents which further comprise one or more further enzymes.
  • enzymes which can preferably be used are all enzymes which can develop a catalytic activity in the agent according to the invention, in particular a lipase, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, xyloglucanase, ß-glucosidase, pectinase, carrageenase, perhydrolase, Oxidase, oxidoreductase or other proteases - which can be distinguished from the proteases according to the invention - and mixtures thereof.
  • Further enzymes are advantageously contained in the agent in an amount of 1 x 10 -8 to 5% by weight based on active protein. Increasingly preferred is each further enzyme in an amount of 1 x 10 -7 to 3% by weight, from 0.00001 to 1% by weight, from 0.00005 to 0.5% by weight, from 0.0001 up to 0.1% by weight and particularly preferably from 0.0001 to 0.05% by weight in agents according to the invention, based on active protein.
  • the enzymes particularly preferably show synergistic cleaning performance against certain dirt or stains, ie the enzymes contained in the agent support each other in their cleaning performance.
  • such a synergism exists between the protease contained according to the invention and a further enzyme of an agent according to the invention, including in particular between the protease mentioned and an amylase and/or a lipase and/or a mannanase and/or a cellulase and/or a pectinase .
  • Synergistic effects can occur not only between different enzymes, but also between one or more enzymes and other ingredients of the agent according to the invention.
  • Textile detergents preferred according to the invention have at least one protease and at least one amylase.
  • textile detergents have at least one protease and at least one cellulase.
  • textile detergents have at least one protease and at least one lipase.
  • textile detergents have at least one protease, at least one amylase and at least one lipase.
  • textile detergents have at least one protease, at least one amylase and at least one cellulase.
  • textile detergents have at least one protease, at least one amylase, at least one cellulase and at least one lipase.
  • Textile detergents which have 3 to 10 different enzymes are particularly preferred, with textile detergents which have 3 to 10 different types of enzymes being particularly preferred in terms of their cleaning performance against a very wide range of stains.
  • proteases are the subtilisins BPN' from Bacillus amyloliquefaciens and Carlsberg from Bacillus! formis, the protease PB92, the subtilisins 147 and 309, the protease from Bacillus lentus, subtilisin DY and the enzymes thermitase, proteinase K and the proteases TW3 and TW7, which are classified as subtilases but no longer as subtilisins in the narrower sense.
  • Subtilisin Carlsberg is available in a further developed form under the trade name Alcalase® from the company Novozymes.
  • subtilisins 147 and 309 are sold by the company Novozymes under the trade names Esperase® and Savinase®, respectively.
  • Protease variants are derived from the protease from Bacillus lentus DSM 5483, described in e.g. WO 95/23221, WO 92/21760 WO 2013/060621 and EP 3660151.
  • proteases are, for example, those under the trade names Durazym®, Relase®, Everlase®, Nafizym®, Natalase®, Kannase®, Progress Uno 101 L® and Ovozyme® from the company Novozymes, which are sold under the trade names, Purafect®, Purafect® OxP, Purafect® Prime, Excellase®, Properase®, Preference P100® and Preference P300® from the company Danisco/DuPont, sold under the trade name Lavergy pro 104 LS® from the company BASF, sold under the trade name Protosol® from the company Advanced Biochemicals Ltd., sold under the trade name Wuxi® from the company Wuxi Snyder Bioproducts Ltd., the enzymes available under the trade names Proleather® and Protease P® from the company Amano Pharmaceuticals Ltd., and the enzymes available under the name Proteinase K-16 from the company Kao Corp.
  • proteases from Bacillus gibsonii and Bacillus pumilus which are disclosed in WO 2008/086916, WO 2007/131656, WO 2017/215925, WO 2021/175696 and WO 2021/175697.
  • Other proteases that can be used are those that are naturally present in the microorganisms Stenotrophomonas maltophilia, in particular Stenotrophomonas maltophilia K279a, Bacillus intermedius and Bacillus sphaericus.
  • amylases are the a-amylases borrowed from Bacillus! formis, Bacillus amyloliquefaciens or Bacillus stearothermophilus and, in particular, their further developments that have been improved for use in detergents or cleaning agents.
  • the enzyme from Bacillus licheniformis is available from the company Novozymes under the name Termamyl® and from the company Danisco/DuPont under the name Purastar® ST. Further development products of this a-amylase are available under the trade names Duramyl® and Termamyl® ultra (both from Novozymes), Purastar® OxAm (Danisco/DuPont) and Keistase® (Daiwa Seiko Inc.).
  • the a-amylase from Bacillus amyloliquefaciens is sold by the Novozymes company under the name BAN®, and derived variants of the a-amylase from Bacillus stearothermophilus under the names BSG® and Novamyl®, also by the Novozymes company. Furthermore, the ⁇ -amylase from Bacillus sp. A 7-7 (DSM 12368) and the cyclodextrin glucanotransferase (CGTase) from Bacillus agaradherens (DSM 9948) should be highlighted. Fusion products of all the molecules mentioned can also be used.
  • Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases are cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. B. the fungal cellulases from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum, which are disclosed in US 4435307, US 5648263, US 5691178, US 5776757 and WO 89/09259. Particularly suitable cellulases are the alkaline or neutral cellulases with color-care properties.
  • cellulases examples include cellulases described in EP 0495257, EP 0531372, WO 96/11262, WO 96/29397 and WO 98/08940.
  • Examples of cellulases with endo-1,4-glucanase activity are described in WO 2002/099091, e.g. those with a sequence of at least 97% identity to the amino acid sequence of positions 1 to 773 of SEQ ID NO: 2 of WO 2002/099091.
  • a further example may include a GH44 xyloglucanase, e.g.
  • a xyloglucanase enzyme with a sequence of at least 60% identity to positions 40 to 559 of SEQ ID NO:2 of WO 2001/062903.
  • Commercially available cellulases include CelluzymeTM, CarezymeTM, Carezyme PremiumTM, CellucleanTM (e.g.
  • CellucleanTM 5000L and CellucleanTM 4000T Celluclean ClassicTM, CellusoftTM, Endolase®, Renozyme® and WhitezymeTM (Novozymes A/S) , ClazinaseTM and Puradax HATM (Genencor International Inc.), KAC-500(B)TM (Kao Corporation), RevitalenzTM 1000, RevitalenzTM 2000 and RevitalenzTM 3000 (DuPont), and Ecostone® and Biotouch® (AB Enzymes ).
  • Lipases or cutinases can be used as further enzymes, in particular because of their triglyceride-cleaving activities, but also in order to generate peracids in situ from suitable precursors.
  • Suitable lipases and cutinases are those of bacterial or fungal origin. Chemically modified or protein engineered mutant enzymes are included. Examples are lipase from Thermomyces, for example from T. lanuginosus (formerly called Humicola lanuginosa), as described in EP 0258068 and EP 0305216, cutinase from Humicola, for example H.
  • insolens (WO 96/13580), lipase from strains of Pseudomonas (some of them now renamed Burkholderia), e.g. P. alcaligenes or P. pseudoalcaligenes, P. cepacia, P. sp. strain SD705, P.
  • Preferred lipases include, for example, the lipases originally available from Humicola lanuginosa (Thermomyces lanuginosus) or further developed therefrom, in particular those with one or more of the following amino acid exchanges starting from the lipase mentioned in the positions D96L, T213R and / or N233R, particularly preferably T213R and N233R.
  • To Preferred commercial lipase products include LipolaseTM, LipexTM, LipolexTM and LipocleanTM (Novozymes A/S), Lumafast (Genencor/DuPont) and Lipomax (Gist-Brocades).
  • oxidoreductases for example oxidases, oxygenases, catalases, peroxidases such as halo-, chloro-, bromo-, lignin-, glucose or manganese peroxidases, dioxygenases or laccases (phenol oxidases, polyphenol oxidases)
  • oxidoreductases for example oxidases, oxygenases, catalases, peroxidases such as halo-, chloro-, bromo-, lignin-, glucose or manganese peroxidases, dioxygenases or laccases (phenol oxidases, polyphenol oxidases)
  • organic, particularly preferably aromatic, compounds that interact with the enzymes are added in order to increase the activity of the relevant oxidoreductases (enhancers) or to ensure the flow of electrons in the case of very different redox potentials between the oxidizing enzymes and the soils (mediators).
  • the enzymes to be used can also be formulated together with accompanying substances, for example from fermentation.
  • the enzymes are preferably used as enzyme liquid formulation(s).
  • the enzymes are generally not provided in the form of pure protein, but rather in the form of stabilized, storable and transportable preparations.
  • These prefabricated preparations include, for example, the solid preparations obtained by granulation, extrusion or lyophilization or, in particular in the case of liquid or gel-like agents, solutions of the enzymes, advantageously as concentrated as possible, with little water and/or mixed with stabilizers or other auxiliaries.
  • the enzymes can be encapsulated for both the solid and liquid dosage forms, for example by spray drying or extrusion of the enzyme solution together with a preferably natural polymer or in the form of capsules, for example those in which the enzymes are enclosed as in a solidified gel or in those of the core-shell type, in which an enzyme-containing core is covered with a water-, air- and/or chemical-impermeable protective layer.
  • Additional active ingredients such as stabilizers, emulsifiers, pigments, bleaches or dyes, can also be applied in superimposed layers.
  • Such capsules are applied using methods known per se, for example by shaking or rolling granulation or in fluid bed processes. Such granules are advantageously low-dust, for example by applying polymeric film formers, and are storage-stable due to the coating.
  • the enzymes can also be incorporated into water-soluble films, such as those used, for example, in the packaging of detergents and cleaning agents in unit dosage form. Such a film allows the enzymes to be released after contact with water.
  • water soluble refers to a film structure that is preferably completely water soluble. Such a film preferably consists of (completely or partially hydrolyzed) polyvinyl alcohol (PVA).
  • PVA polyvinyl alcohol
  • a further subject of the invention is a method for cleaning textiles and/or hard surfaces, in particular dishes, which is characterized in that an agent according to the invention is used in at least one method step.
  • the method described is characterized in that the protease is at a temperature of about 0°C to about 100°C, preferably about 20°C to about 60°C and more preferably about 20°C to about 40°C is used.
  • Methods for cleaning textiles are generally characterized by the fact that various cleaning-active substances are applied to the items to be cleaned in several process steps and washed off after the exposure time, or that the items to be cleaned are treated in some other way with a detergent or a solution or dilution of this agent.
  • proteases according to the invention naturally already have a hydrolytic activity and also develop this in media that otherwise have no cleaning power, such as in mere buffer, a single and / or the only step of such a method can consist of a protease according to the invention as the only cleaning-active component is brought into contact with the soiling, preferably in a buffer solution or in water. This represents a further embodiment of this subject matter of the invention.
  • Alternative embodiments of this subject matter of the invention also represent processes for the treatment of textile raw materials or for textile care, in which a protease according to the invention becomes active in at least one process step.
  • processes for textile raw materials, fibers or textiles with natural components are preferred, and especially for those with wool or silk.
  • the invention also covers the use of the proteases described herein in detergents or cleaning agents, for example as described above, for (improved) removal of peptide or protein-containing soils, for example from textiles and/or hard surfaces.
  • the invention relates to the use of a protease according to the invention described herein in a washing or cleaning agent to improve the cleaning performance on at least one and increasingly preferably on two, three, four or five protease-sensitive soil(s), preferably from the blood -, egg (yellow), milk and other protein-containing soils is/are selected, the improvement in cleaning performance compared to a reference protease, as described in Example 2, being determined, in particular in a temperature range from about 20 ° C to about 40°C.
  • the invention relates to the use of a protease in a detergent or cleaning agent, in particular liquid detergent or cleaning agent, to improve the cleaning performance on at least one and increasingly preferably on two, three, four or five protease-sensitive soil(s), which is/are preferably selected from the group consisting of blood, egg (yellow), milk and other protein-containing soils, the improvement in cleaning performance compared to a reference protease , as described in Example 2, is determined, in particular in a temperature range of about 20 ° C to about 40 ° C, wherein the protease is a protease that has proteolytic activity and comprises an amino acid sequence corresponding to that in SEQ ID NO: 1 specified amino acid sequence over their total length to at least 70% and increasingly preferably to at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%
  • Protease activity was determined in a batch assay using casein as substrate.
  • the final concentration of the substrate solution was 12 mg/ml casein (prepared according to Hammarsten; Merck, Darmstadt, #2242) and 30 mM Tris in synthetic tap water.
  • Synthetic tap water is a solution of 0.029% (w/v) CaCh • 2 H2O, 0.014% (w/v) MgCh • 6 H2O and 0.021% (w/v) NaHCCh with 15° dH (German hardness).
  • the substrate solution was heated to 70°C and the pH adjusted to 8.5 at 50°C using 0.1N NaOH.
  • the protease solution was prepared by adding 2% (w/v) anhydrous pentasodium tripolyphosphate to synthetic tap water and adjusting to pH 8.5 with hydrochloric acid. 200 ⁇ l of the enzyme solution were added to 600 ⁇ l of the casein solution. The mixture was incubated at 50°C for 15 minutes. The reaction was stopped by adding 600 ⁇ l of 0.44 M trichloroacetic acid (TCA), 0.22 M sodium acetate in 3% (w/v). After cooling on ice for 15 minutes, the TCA-insoluble protein was removed by centrifugation.
  • TCA trichloroacetic acid
  • the cleaning performance was determined in miniwash tests with Bacillus subtilis culture supernatants containing the expressed protease variants.
  • the supernatants were used with the same activity as the benchmark (1.15 pg/ml active enzyme protein in the wash liquor).
  • AY ariante was determined for each protease and all AYvariant values of all stains per variant were summed to determine SAY ariante.
  • both AYpi (for each soiling) and SAYPI (total cleaning performance) were normalized to 100% and the relative cleaning performance of the variants according to the invention was calculated. A >15% increase in overall performance is considered a significant performance increase.
  • proteases P2 to P8 according to the invention show significantly improved washing performance at both 20 ° C and 40 ° C compared to the benchmark protease P1.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)

Abstract

L'invention concerne des protéases qui ont une activité protéolytique et comprennent une séquence d'acides aminés qui est au moins 70 % et avec une préférence croissante au moins 71 %, 72 %, 73 %, 74 %, 75 %, 76 %, 77 %, 78 %, 79 %, 80 %, 81 %, 82 %, 83 %, 84 %, 85 %, 86 %, 87 %, 88 %, 89 %, 90 %, 90,5 %, 91 %, 91,5 %, 92 %, 92,5 %, 93 %, 93,5 %, 94 %, 94,5 %, 95 %, 95,5 %, 96 %, 96,5 %, 97 %, 97,5 % et 98 % identique à la séquence d'acides aminés indiquée dans SEQ ID NO : 1 sur toute sa longueur, la protéase, dans chaque cas sur la base de la numérotation selon SEQ ID NO : 1, (i) ayant des substitutions d'acides aminés P9T, S89A, N130D, T133A, N144K, S189T, Y217M, S224A, N252T et Q271E aux positions correspondant aux positions 9, 89, 130, 133, 144, 189, 217, 224, 252 et 271, et (ii) ayant au moins une et avec une préférence croissante deux, trois, quatre, cinq ou six substitutions d'acides aminés au moins à une et avec une préférence croissante deux, trois, quatre, cinq ou six des positions correspondant aux positions 6, 61, 62, 101, 170 et 188. L'invention concerne également la production et l'utilisation desdites protéases. Les protéases de ce type présentent une très bonne performance de nettoyage.
PCT/DE2023/100529 2022-08-16 2023-07-19 Variants ix de protéase à performance améliorée WO2024037685A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102022208890.5 2022-08-16
DE102022208890.5A DE102022208890A1 (de) 2022-08-16 2022-08-16 Leistungsverbesserte protease-varianten ix
DE102022208630.9 2022-08-19
DE102022208630 2022-08-19

Publications (1)

Publication Number Publication Date
WO2024037685A1 true WO2024037685A1 (fr) 2024-02-22

Family

ID=87762954

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2023/100529 WO2024037685A1 (fr) 2022-08-16 2023-07-19 Variants ix de protéase à performance améliorée

Country Status (1)

Country Link
WO (1) WO2024037685A1 (fr)

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435307A (en) 1980-04-30 1984-03-06 Novo Industri A/S Detergent cellulase
EP0258068A2 (fr) 1986-08-29 1988-03-02 Novo Nordisk A/S Additif enzymatique pour détergent
EP0305216A1 (fr) 1987-08-28 1989-03-01 Novo Nordisk A/S Lipase recombinante de humicola et procédé de production de lipases recombinantes de humicola
WO1989009259A1 (fr) 1988-03-24 1989-10-05 Novo-Nordisk A/S Preparation de cellulase
EP0495257A1 (fr) 1991-01-16 1992-07-22 The Procter & Gamble Company Compositions de détergent compactes contenant de la cellulase de haute activité
WO1992021760A1 (fr) 1991-05-29 1992-12-10 Cognis, Inc. Enzymes proteolytiques mutantes tirees de bacillus
EP0531372A1 (fr) 1990-05-09 1993-03-17 Novo Nordisk As Preparation de cellulase comprenant un enzyme d'endoglucanase.
WO1995023221A1 (fr) 1994-02-24 1995-08-31 Cognis, Inc. Enzymes ameliorees et detergents les contenant
WO1996011262A1 (fr) 1994-10-06 1996-04-18 Novo Nordisk A/S Enzyme et preparation enzymatique presentant une activite endoglucanase
WO1996013580A1 (fr) 1994-10-26 1996-05-09 Novo Nordisk A/S Enzyme a activite lipolytique
WO1996029397A1 (fr) 1995-03-17 1996-09-26 Novo Nordisk A/S Nouvelles endoglucanases
US5648263A (en) 1988-03-24 1997-07-15 Novo Nordisk A/S Methods for reducing the harshness of a cotton-containing fabric
WO1998008940A1 (fr) 1996-08-26 1998-03-05 Novo Nordisk A/S Nouvelle endoglucanase
WO2001062903A1 (fr) 2000-02-24 2001-08-30 Novozymes A/S Xyloglucanases appartenant a la famille 44
WO2002099091A2 (fr) 2001-06-06 2002-12-12 Novozymes A/S Endo-beta-1,4-glucanase
WO2007131656A1 (fr) 2006-05-11 2007-11-22 Henkel Ag & Co. Kgaa Subtilisine dérivée de bacillus pumilus et produits détergents et nettoyants contenant cette nouvelle subtilisine
WO2008086916A1 (fr) 2007-01-16 2008-07-24 Henkel Ag & Co. Kgaa Nouvelle protéase alcaline issue de bacillus gibsonii et détergents et nettoyants contenant cette nouvelle protéase alcaline
WO2009121725A1 (fr) 2008-04-02 2009-10-08 Henkel Ag & Co. Kgaa Agents de lavage et de nettoyage contenant des protéases sécrétées par xanthomonas
WO2013060621A1 (fr) 2011-10-28 2013-05-02 Henkel Ag & Co. Kgaa Variants de protéase à performance améliorée et thermiquement stables
WO2017215925A1 (fr) 2016-06-15 2017-12-21 Henkel Ag & Co. Kgaa Protéase de bacillus gibsonii et variantes de celle-ci
EP3660151A1 (fr) 2018-11-29 2020-06-03 Henkel AG & Co. KGaA Variantes de prothèse stables au stockage et à la performance améliorée
WO2021175696A1 (fr) 2020-03-03 2021-09-10 Henkel Ag & Co. Kgaa Variants de protéase vi à stabilité améliorée
WO2021175697A1 (fr) 2020-03-03 2021-09-10 Henkel Ag & Co. Kgaa Variantes de protéase à performance améliorée vii
WO2021219296A1 (fr) * 2020-04-29 2021-11-04 Henkel Ag & Co. Kgaa Détergent pour textiles fortement alcalin contenant une protéase

Patent Citations (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435307A (en) 1980-04-30 1984-03-06 Novo Industri A/S Detergent cellulase
EP0258068A2 (fr) 1986-08-29 1988-03-02 Novo Nordisk A/S Additif enzymatique pour détergent
EP0305216A1 (fr) 1987-08-28 1989-03-01 Novo Nordisk A/S Lipase recombinante de humicola et procédé de production de lipases recombinantes de humicola
US5691178A (en) 1988-03-22 1997-11-25 Novo Nordisk A/S Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase
US5648263A (en) 1988-03-24 1997-07-15 Novo Nordisk A/S Methods for reducing the harshness of a cotton-containing fabric
WO1989009259A1 (fr) 1988-03-24 1989-10-05 Novo-Nordisk A/S Preparation de cellulase
US5776757A (en) 1988-03-24 1998-07-07 Novo Nordisk A/S Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase and method of making thereof
EP0531372A1 (fr) 1990-05-09 1993-03-17 Novo Nordisk As Preparation de cellulase comprenant un enzyme d'endoglucanase.
EP0495257A1 (fr) 1991-01-16 1992-07-22 The Procter & Gamble Company Compositions de détergent compactes contenant de la cellulase de haute activité
WO1992021760A1 (fr) 1991-05-29 1992-12-10 Cognis, Inc. Enzymes proteolytiques mutantes tirees de bacillus
WO1995023221A1 (fr) 1994-02-24 1995-08-31 Cognis, Inc. Enzymes ameliorees et detergents les contenant
WO1996011262A1 (fr) 1994-10-06 1996-04-18 Novo Nordisk A/S Enzyme et preparation enzymatique presentant une activite endoglucanase
WO1996013580A1 (fr) 1994-10-26 1996-05-09 Novo Nordisk A/S Enzyme a activite lipolytique
WO1996029397A1 (fr) 1995-03-17 1996-09-26 Novo Nordisk A/S Nouvelles endoglucanases
WO1998008940A1 (fr) 1996-08-26 1998-03-05 Novo Nordisk A/S Nouvelle endoglucanase
WO2001062903A1 (fr) 2000-02-24 2001-08-30 Novozymes A/S Xyloglucanases appartenant a la famille 44
WO2002099091A2 (fr) 2001-06-06 2002-12-12 Novozymes A/S Endo-beta-1,4-glucanase
WO2007131656A1 (fr) 2006-05-11 2007-11-22 Henkel Ag & Co. Kgaa Subtilisine dérivée de bacillus pumilus et produits détergents et nettoyants contenant cette nouvelle subtilisine
EP2016175A1 (fr) 2006-05-11 2009-01-21 Henkel AG & Co. KGaA Subtilisine dérivée de bacillus pumilus et produits détergents et nettoyants contenant cette nouvelle subtilisine
WO2008086916A1 (fr) 2007-01-16 2008-07-24 Henkel Ag & Co. Kgaa Nouvelle protéase alcaline issue de bacillus gibsonii et détergents et nettoyants contenant cette nouvelle protéase alcaline
WO2009121725A1 (fr) 2008-04-02 2009-10-08 Henkel Ag & Co. Kgaa Agents de lavage et de nettoyage contenant des protéases sécrétées par xanthomonas
WO2013060621A1 (fr) 2011-10-28 2013-05-02 Henkel Ag & Co. Kgaa Variants de protéase à performance améliorée et thermiquement stables
WO2017215925A1 (fr) 2016-06-15 2017-12-21 Henkel Ag & Co. Kgaa Protéase de bacillus gibsonii et variantes de celle-ci
EP3660151A1 (fr) 2018-11-29 2020-06-03 Henkel AG & Co. KGaA Variantes de prothèse stables au stockage et à la performance améliorée
WO2021175696A1 (fr) 2020-03-03 2021-09-10 Henkel Ag & Co. Kgaa Variants de protéase vi à stabilité améliorée
WO2021175697A1 (fr) 2020-03-03 2021-09-10 Henkel Ag & Co. Kgaa Variantes de protéase à performance améliorée vii
WO2021219296A1 (fr) * 2020-04-29 2021-11-04 Henkel Ag & Co. Kgaa Détergent pour textiles fortement alcalin contenant une protéase

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
ALTSCHUL ET AL.: "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402, XP002905950, DOI: 10.1093/nar/25.17.3389
BENDER ET AL., J. AM. CHEM. SOC., vol. 88, no. 24, 1966, pages 5890 - 5913
CHENNA ET AL.: "Multiple sequence alignment with the Clustal series of programs", NUCLEIC ACID RES., vol. 31, 2003, pages 3497 - 3500, XP002316493, DOI: 10.1093/nar/gkg500
GORNALL ET AL., J. BIOL. CHEM., vol. 177, 1948, pages 751 - 766
MIYAJI T ET AL: "Purification and molecular characterization of subtilisin-like alkaline protease BPP-A from Bacillus pumilus strain MS-1", LETTERS IN APPLIED MICROBIOLOGY, OXFORD, GB, vol. 42, no. 3, 1 March 2006 (2006-03-01), pages 242 - 247, XP002451280, ISSN: 1472-765X, DOI: 10.1111/J.1472-765X.2005.01851.X *
NOTREDAME ET AL.: "T-Coffee: A novel method for multiple sequence alignments", J. MOL. BIOL., vol. 302, 2000, pages 205 - 217, XP004469125, DOI: 10.1006/jmbi.2000.4042
PHILIP N. BRYAN: "Protein engineering of subtilisin", BIOCHIMICA ET BIOPHYSICA ACTA. PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, vol. 1543, no. 2, 1 December 2000 (2000-12-01), AMSTERDAM; NL, pages 203 - 222, XP055251064, ISSN: 0167-4838, DOI: 10.1016/S0167-4838(00)00235-1 *
R. SIEZENVON R. BOTTC. BETZEL: "Subtilases: Subtilisin-like Proteases", SUBTILISIN ENZYMES, 1996, pages 75 - 95
SAMBROOK, JFRITSCH, E.FMANIATIS, T: "Molecular cloning: a laboratory manual", 2001, COLD SPRING LABORATORY PRESS
TENSIDE, BAND, vol. 7, 1970, pages 125 - 132
Z.B. ALTSCHUL ET AL.: "Basic local alignment search tool", J. MOL. BIOL., vol. 215, 1990, pages 403 - 410, XP002949123, DOI: 10.1006/jmbi.1990.9999

Similar Documents

Publication Publication Date Title
EP4114933A1 (fr) Variantes de protéase à performance améliorée vii
EP4114934A1 (fr) Variants de protéase vi à stabilité améliorée
EP4253511A2 (fr) Variants de protéases présentant une performance ameliorée et stabilité au stockage
EP3963065A1 (fr) Protéases présentant une stabilité enzymatique améliorée dans des détergents et produits de nettoyage iii
EP3679131B1 (fr) Variantes de protéases à performances améliorées
EP3679133A1 (fr) Variantes de protéases à performances améliorées
WO2020221578A1 (fr) Performance de nettoyage améliorée contre des salissures vi sensibles aux protéines
WO2020221580A1 (fr) Performance de nettoyage améliorée contre des salissures v sensibles à des protéines
EP3660146B1 (fr) Variantes de prothèse stables au stockage et à la performance améliorée
EP3679132B1 (fr) Variantes de protéase à performances améliorées
EP3458583B1 (fr) Protéases à performances améliorées
EP3433359B1 (fr) Performance de nettoyage améliorée sur des salissures sensibles aux protéines
DE102018004207A1 (de) Leistungsverbesserte Varianten der alkalischen Protease aus B. lentus
WO2024037685A1 (fr) Variants ix de protéase à performance améliorée
WO2024037686A1 (fr) Variants x de protéase à performance améliorée
WO2024125929A1 (fr) Détergents et agents de nettoyage contenant une protéase
DE102022208890A1 (de) Leistungsverbesserte protease-varianten ix
WO2024125930A1 (fr) Détergents et agents de nettoyage contenant une protéase
DE102022208891A1 (de) Leistungsverbesserte protease-varianten x
DE102022205594A1 (de) Leistungsverbesserte und lagerstabile protease-varianten
EP4335921A1 (fr) Produit détergent et nettoyant contenant de la tannase ii
EP4335922A1 (fr) Produit détergent et nettoyant contenant de la tannase i
DE102017215628A1 (de) Leistungsverbesserte Proteasevarianten I
DE102021207704A1 (de) Leistungsverbesserte Proteasevarianten VIII
DE102018208777A1 (de) Leistungsverbesserte Proteasevarianten V

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23758225

Country of ref document: EP

Kind code of ref document: A1